This company has been marked as potentially delisted and may not be actively trading. Intensity Therapeutics, Inc. Common stock (INTS) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesOwnershipShort InterestTrendsBuy This Stock Intensity Therapeutics, Inc. Common stock Earnings Summary Intensity Therapeutics, Inc. Common stock issued Q1 2025 earnings on May 13, 2025, reporting an EPS of -$0.22, which missed analysts' consensus estimates of -$0.21 by $0.01. With a trailing EPS of -$1.07, Intensity Therapeutics, Inc. Common stock's earnings are expected to grow next year, from ($1.18) to ($1.00) per share. Latest Q1 Earnings DateMay. 13EstimatedConsensus EPS (May. 13) -$0.21 Actual EPS (May. 13) -$0.22 Missed By -$0.01 Q1 2025 Earnings ResourcesQ1 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)Powered by Get Intensity Therapeutics, Inc. Common stock Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intensity Therapeutics, Inc. Common stock and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataINTS Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Intensity Therapeutics, Inc. Common stock Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20251-$0.28-$0.28-$0.28Q2 20251-$0.31-$0.31-$0.31Q3 20251-$0.33-$0.33-$0.33Q4 20251-$0.35-$0.35-$0.35 Intensity Therapeutics, Inc. Common stock Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025-$0.21-$0.22 -$0.01-$0.22--3/13/2025Q4 2024-$0.23-$0.22+$0.01-$0.22--8/9/2024--$0.32-$0.36 -$0.04-$0.36--5/9/2024Q1 2024--$0.34 -$0.34-$0.34--3/14/2024Q4 2023--$0.12 -$0.12-$0.12--11/13/2023Q3 2023--$0.17 -$0.17-$0.17--8/14/2023Q2 2023--$1.43 -$1.43-$1.43-- Intensity Therapeutics, Inc. Common stock Earnings - Frequently Asked Questions When did Intensity Therapeutics, Inc. Common stock announce their last quarterly earnings? Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) last announced its quarterly earning data on Tuesday, May 13, 2025. Learn more on INTS's earnings history. Did Intensity Therapeutics, Inc. Common stock beat their earnings estimates last quarter? In the previous quarter, Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) missed the analysts' consensus estimate of ($0.21) by $0.01 with a reported earnings per share (EPS) of ($0.22). Learn more on analysts' earnings estimate vs. INTS's actual earnings. How much profit does Intensity Therapeutics, Inc. Common stock generate each year? Intensity Therapeutics, Inc. Common stock (NASDAQ:INTS) has a recorded net income of -$10.54 million. INTS has generated -$1.07 earnings per share over the last four quarters. What is Intensity Therapeutics, Inc. Common stock's EPS forecast for next year? Intensity Therapeutics, Inc. Common stock's earnings are expected to grow from ($1.18) per share to ($1.00) per share in the next year. More Earnings Resources from MarketBeat Related Companies Protalix BioTherapeutics Earnings Results Compugen Earnings Results Exozymes Earnings Results Editas Medicine Earnings Results Protara Therapeutics Earnings Results Vigil Neuroscience Earnings Results Fate Therapeutics Earnings Results Alpha Cognition Earnings Results Alector Earnings Results Invivyd Earnings Results Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Alibaba's Earnings Just Changed Everything for the StockCisco Stock Eyes New Highs in 2025 on AI, Earnings, UpgradesSymbotic Gets Big Earnings Lift: Is the Stock Investable Again?D-Wave Pushes Back on Short Seller Case With Strong EarningsAppLovin Surges on Earnings: What's Next for This Tech Standout?Can Shopify Stock Make a Comeback After an Earnings Sell-Off?Rocket Lab: Earnings Miss But Neutron Momentum Holds This page (NASDAQ:INTS) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump Predicts Dollar DownfallREAD THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...Augusta Precious Metals | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredCollect $7k per month from Tesla’s SECRET dividendI just uncovered a strategy that could pay out up to $7,013 every month—without needing a traditional dividend...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intensity Therapeutics, Inc. Common stock Please log in to your account or sign up in order to add this asset to your watchlist. Share Intensity Therapeutics, Inc. Common stock With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy INTS Stock Free INTS Stock Alerts